1-(Difluoromethoxy)-2-ethynylbenzene, 96%, 100mg

5,7-dimethyl-2-sulfanylidene-1H,2H,3H,4H-pyrido[2,3-d]pyrimidin-4-one, 98%, 250mg

2-(4-FLUOROPHENOXY)PROPIONIC ACID, 95.0%, 1g

2-cyclohexyl-5-methyl-2,3-dihydro-1H-pyrazol-3-one, 97%, 1g

2-Butoxyacetic acid, 95.0%, 1g

1-Benzyl 2-methyl (2S,4R)-4-((tert-butoxycarbonyl)amino)pyrrolidine-1,2-dicarboxylate, 97%, 5g

Neu5Ac alpha(2-6) N-Glycan 2AB (500pmol/vial)1vial

8-Bromo[1,2,4]triazolo[1,5-a]pyridine, 95.0%, 10g

(S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride, 97.0%, 1g

4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)phthalic acid, 95.0%, 1g

3-(Methoxymethyl)azetidine hydrochloride, 92.0%, 5g

Ethyl vanillin, 95.0%, 500g

3-BROMO-2-HYDROXY-5-METHOXYBENZALDEHYDE, 95.0%, 10g